Explore more publications!
DC STEM Digest
Got News to Share?

DC STEM Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 3, 2025

MyComuni Announces New Community Hub for Nonprofits and Organizations to Build Connections and Receive Support
December 3, 2025

MyComuni Announces New Community Hub for Nonprofits and Organizations to Build Connections and Receive Support

Indeterminate EIN Presswire
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025
December 3, 2025

Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025

Indeterminate GlobeNewswire
Orezone Intercepts 3.28 g/t Gold Over 26.00m and 5.55 g/t Gold Over 15.00m at P17 Zone in Advance of Hard Rock First Gold
December 3, 2025

Orezone Intercepts 3.28 g/t Gold Over 26.00m and 5.55 g/t Gold Over 15.00m at P17 Zone in Advance of Hard Rock First Gold

Indeterminate GlobeNewswire
The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN
December 3, 2025

The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN

Indeterminate GlobeNewswire
Descartes Announces Fiscal 2026 Third Quarter Financial Results
December 3, 2025

Descartes Announces Fiscal 2026 Third Quarter Financial Results

Indeterminate GlobeNewswire
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting
December 3, 2025

Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting

Indeterminate GlobeNewswire
NowVertical Promotes Christine Nelson to Permanent Chief Financial Officer
December 3, 2025

NowVertical Promotes Christine Nelson to Permanent Chief Financial Officer

Indeterminate GlobeNewswire
MKS Inc. Named One of America’s Most Responsible Companies
December 3, 2025

MKS Inc. Named One of America’s Most Responsible Companies

Indeterminate GlobeNewswire
reAlpha (NASDAQ: AIRE) Appoints Thomas Kutzman to Lead Brokerage Division as CEO of reAlpha Realty
December 3, 2025

reAlpha (NASDAQ: AIRE) Appoints Thomas Kutzman to Lead Brokerage Division as CEO of reAlpha Realty

Indeterminate GlobeNewswire
Innventure to Participate in Upcoming Investor Conferences
December 3, 2025

Innventure to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
JMU experts available to provide essential holiday tips
December 3, 2025

JMU experts available to provide essential holiday tips

Indeterminate GlobeNewswire
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 3, 2025

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
December 3, 2025

Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference

Indeterminate GlobeNewswire
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
December 3, 2025

Soleno Therapeutics Announces the Passing of Board Member William G. Harris

Indeterminate GlobeNewswire
TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities
December 3, 2025

TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities

Indeterminate GlobeNewswire
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update
December 3, 2025

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update

Indeterminate GlobeNewswire
nCino Reports Third Quarter Fiscal Year 2026 Financial Results
December 3, 2025

nCino Reports Third Quarter Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire
Nano One Materials Corp. Announces Overnight Marketed Offering
December 3, 2025

Nano One Materials Corp. Announces Overnight Marketed Offering

Indeterminate GlobeNewswire
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Late-Breaking Oral Presentations in EGFR Atypical and EGFR exon 20 NSCLC at the ESMO Asia Congress 2025
December 3, 2025

ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Late-Breaking Oral Presentations in EGFR Atypical and EGFR exon 20 NSCLC at the ESMO Asia Congress 2025

Indeterminate GlobeNewswire
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 3, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions